PBM Reporting Transparency Act

Hozzl · 2026-02-19T05:23:26Z

Explore the details of Senate Bill 3729 PBM Reporting Transparency Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

2/19/2026, 5:23 AM

Summary of Bill S 3729

The PBM Reporting Transparency Act, introduced in the 119th Congress, aims to enhance transparency in pharmacy benefit managers (PBMs) reporting practices. The bill, designated as S.3729 and introduced on January 29, 2026, focuses on requiring PBMs to provide detailed reports and disclosures to improve oversight and accountability. Specific directives regarding reporting requirements for PBMs are likely included in the bill text, promoting greater transparency in their operations. For more detailed information, the official PDF version of the bill can be accessed using the provided link.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3729

Bill S 3729 is currently in the status of Bill Introduced since January 29, 2026. Bill S 3729 was introduced during Congress 119 and was introduced to the Senate on January 29, 2026. Bill S 3729's most recent activity was Read twice and referred to the Committee on Finance. as of January 29, 2026

Bipartisan Support of Bill S 3729

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3729

Primary Policy Focus

Alternate Title(s) of Bill S 3729

A bill to require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.